Major breakthrough after pill wipes out deadliest cancer in patients

Résumé détaillé
A new pill is ‘closest thing to a cure’ for pancreatic cancer (Picture: Alamy Stock Photo) A new once-a-day pill has wiped out pancreatic cancer in some patients in a huge…
A new once-a-day pill has wiped out pancreatic cancer in some patients in a huge breakthrough for treatment.
One in 12 patients had their advanced pancreatic cancer completely eradicated using the drug combined with chemotherapy, according to a clinical trial.
The lead medic on the trial said the results represented the ‘closest’ thing to a ‘cure’ for some patients.
Draxonrasib, when used alongside chemotherapy, could increase the proportion of patients alive after one year compared to standard treatment.
In May, the drug was found to almost double survival time for patients with aggressive and advanced pancreatic cancer compared to chemo alone.
The pill also caused fewer side effects so experts are hailing it as a breakthrough in treating people with the disease.
Daraxonrasib works by locking onto the mutated KRAS gene, which is found in more than nine in 10 pancreatic tumours and continuously signals cancer cells to grow.
In the new study, presented at the European Organisation for Research and Treatment of Cancer in Barcelona, tumours shrank or disappeared in 60.7% of patients given daraxonrasib and chemotherapy.
This included complete responses in 8.2% of patients over a typical follow-up of 18 months, meaning their tumours were no longer detectable.
Début de l'article, extrait de Metro. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (metro.co.uk)

/2026/11/20/6affdecadf9ed341063480.jpg)


